Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615495 · ClinicalTrials.gov registry record
Flourish™ Pediatric Esophageal Atresia
A clinical trial, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 21
- Enrollment target
NCT03615495 is a clinical trial that has completed, run by Cook Research Incorporated. The registered enrollment target is 21 participants.
The verdict
NCT03615495 has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study is continued evaluation of the safety and probable benefit of the Flourish Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.
Interventions
- DEVICE Flourish Pediatric Esphogeal Atresia device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2023-11-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615495
The ClinicalTrials.gov registry entry for NCT03615495 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flourish Pediatric Esphogeal Atresia device is the first listed.
NCT03615495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03615495 about?
NCT03615495 is a clinical study titled "Flourish™ Pediatric Esophageal Atresia". This study is continued evaluation of the safety and probable benefit of the Flourish Pediatric Esophageal Atresia device through the Humanitarian Device Exemption (HDE) pathway.
What is the current status of trial NCT03615495?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-11-05. Estimated completion is 2023-11-27.
What interventions are being tested in trial NCT03615495?
The interventions under investigation include: Flourish Pediatric Esphogeal Atresia device (DEVICE).
Who is sponsoring clinical trial NCT03615495?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.